AstraZeneca is paying CSPC Pharmaceutical Group $110 million up front to tap that China-based biotech’s artificial intelligence-driven technology for discovering and developing novel oral drugs. The R ...
AstraZeneca has admitted that its COVID-19 vaccine could cause a rare but deadly blood-clotting condition, potentially exposing the UK pharmaceutical giant to tens of millions in lawsuits brought by ...
The FDA has approved AstraZeneca’s Saphnelo autoinjector for subcutaneous self-administration in adults with moderate to severe systemic lupus erythematosus (SLE) receiving standard therapy. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results